Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Arthritis Res Ther · 2011 · PMC3334628 · PMID 22044682

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

not quite statistically significantP = 0.056so close (0.05 < p ≤ 0.1)

As shown in Figure 6a , the basal tear fluid secretion rate was significantly greater after LTBR-Ig treatment for 4 weeks compared to MOPC-21 treated control mice ( P = 0.0002), but after 8 weeks of treatment the difference was not quite statistically significant ( P = 0.056), although a protective trend was apparent.

also in 341 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.